“…18,26 Serum-based tests including PCR and pp65 antigenemia have proven useful in transplant patients for determining when preemptive treatment should be initiated. 10,12,[28][29][30] In contrast, these noninvasive tests seem to be less useful for predicting tissue-invasive disease in patients with IBD. Our data demonstrate that only 31% of patients overall, including 50% with high-grade CMV, had evidence of systemic infection.…”